Jerky Movement with Ceftazidime: A Case of Ceftazidime-Induced Neurotoxicity with a Review of the Literature

Jerky Movement with Ceftazidime: A Case of Ceftazidime-Induced Neurotoxicity with a Review of the Literature

Neurotoxicity manifested as confusion and seizures has been recognized as a side effect of multiple cephalosporins including ceftazidime. Renal impairment and inappropriate dosing are the most common contributors to the development of neurological abnormalities in patients receiving these antibiotic...

Full description

Bibliographic Details
Main Authors:	Mohammed Al-Sadawi, Romy Rodriguez Ortega, Natalie Sun, Madina Abdurahimova, Samy I. McFarlane
Format:	Article
Language:	English
Published:	Hindawi Limited 2019-01-01
Series:	Case Reports in Medicine
Online Access:	http://dx.doi.org/10.1155/2019/8936478

Similar Items

Ceftazidime-Resistant Salmonella enterica, Morocco
by: Brahim Bouchrif, et al.
Published: (2009-10-01)

Ceftazidime-induced myoclonus and encephalopathy in hemodialysis patient
by: J Joseph, et al.
Published: (2015-01-01)

Ceftazidime as an empiric therapy for neonatal sepsis
by: Indrayady Indrayady, et al.
Published: (2021-08-01)

Resistance to ceftazidime–avibactam and underlying mechanisms
by: Yuhang Wang, et al.
Published: (2020-09-01)

Perbandingan Efektivitas Kombinasi Ceftazidime + Amikasin dan Ceftazidime sebagai Antibiotik Empiris Demam Neutropenia pada Keganasan
by: Agustinus William, et al.
Published: (2016-11-01)

In vitro activity of ceftazidime/avibactam against ceftazidime-resistant Enterobacterales and Pseudomonas aeruginosa from hospitalised patients in Germany
by: Michael Kresken, et al.
Published: (2021-06-01)

Metabolic mechanism of ceftazidime resistance in Vibrio alginolyticus
by: Liu SR, et al.
Published: (2019-02-01)

Clinical Pharmacology of Ceftazidime in Neonates: Effects and Pharmacokinetics
by: Gian Maria Pacifici, et al.
Published: (2017-05-01)

Synthesis of new derivatives of Ceftazidime as possible Prodrugs
by: Shakir M. Alwan, et al.
Published: (2017-03-01)

New Spectrophotometric Method for Estimation of Ceftazidime in pure and pharmaceutical dosage
by: Nibras Sabah Mohammed, et al.
Published: (2019-10-01)

Susceptibility of bacterial endophthalmitis isolates to vancomycin, ceftazidime, and amikacin
by: Kuan-Jen Chen, et al.
Published: (2021-08-01)

Microspectrofluorimetry to dissect the permeation of ceftazidime in Gram-negative bacteria
by: Anas Allam, et al.
Published: (2017-04-01)

Development of ceftazidime resistance in an acute Burkholderia pseudomallei infection
by: Sarovich DS, et al.
Published: (2012-08-01)

In silico ADME and Toxicity Prediction of Ceftazidime and Its Impurities
by: Ying Han, et al.
Published: (2019-04-01)

Pharmacokinetics of ceftazidime administered to lactating and non-lactating goats
by: R. Rule, et al.
Published: (2011-05-01)

Ceftazidime-Avibactam Therapy Versus Ceftazidime-Avibactam-Based Combination Therapy in Patients With Carbapenem-Resistant Gram-Negative Pathogens: A Meta-Analysis
by: Dan Li, et al.
Published: (2021-09-01)

Efficacy of ceftazidime-avibactam in the treatment of infections due to Carbapenem-resistant Enterobacteriaceae
by: Basem M. Alraddadi, et al.
Published: (2019-09-01)

Reduced Ceftazidime-Avibactam Susceptibility in KPC-Producing Klebsiella pneumoniae From Patients Without Ceftazidime-Avibactam Use History – A Multicenter Study in China
by: Xiaoyan Cui, et al.
Published: (2020-06-01)

Severe ceftazidime-induced drug reaction with eosinophilia and systemic symptoms (DRESS)
by: Picard Matthieu, et al.
Published: (2011-11-01)

Absorption Kinetics of Subcutaneously Administered Ceftazidime in Hypoperfused Guinea Pigs
by: Tsuyoshi Ebihara, MS, et al.
Published: (2015-12-01)

Retinal toxicity of ceftazidime in the infusion fluid for vitrectomy in the rabbit eye
by: Ismael Ribeiro, et al.

Influence of the structure of ceftazidime on obtaining biologically active cellulosic bandage
by: Rodić-Grabovac Branka B., et al.
Published: (2017-01-01)

Biological and physicochemical stability of ceftazidime and aminophylline on glucose parenteral solution
by: Carolina Alves dos Santos, et al.
Published: (2012-12-01)

Comparison of the <it>in vitro </it>and <it>in vivo </it>susceptibilities of <it>Burkholderia mallei </it>to Ceftazidime and Levofloxacin
by: Torres Alfredo G, et al.
Published: (2009-05-01)

Ceftazidime Is the Key Diversification and Selection Driver of VIM-Type Carbapenemases
by: Laura Martínez-García, et al.
Published: (2018-05-01)

In vitro Optimization of Ceftazidime/Avibactam for KPC-Producing Klebsiella pneumoniae
by: Yanqin Huang, et al.
Published: (2021-03-01)

Ceftazidime-Avibactam Combination Therapy Compared to Ceftazidime-Avibactam Monotherapy for the Treatment of Severe Infections Due to Carbapenem-Resistant Pathogens: A Systematic Review and Network Meta-Analysis
by: Marco Fiore, et al.
Published: (2020-07-01)

Cytotoxicity towards human endothelial cells, induced by neutrophil myeloperoxidase: protection by ceftazidime
by: M. Mathy-Hartert, et al.
Published: (1995-01-01)

Antimicrobial Resistance to Ceftazidime and Ceftriaxone, and Detection of TEM Gene in Esherchia Coli
by: Jahani, S, et al.
Published: (2015-01-01)

Application of the Graphene/ZnO Composites in Treatment of the Simulated Ceftazidime Wastewater
by: Qiong He
Published: (2017-12-01)

Interactions between Avibactam and Ceftazidime-Hydrolyzing Class D β-Lactamases
by: Jean-Marie Frère, et al.
Published: (2020-03-01)

Economic Evaluation of the Use of Cefotaxime and Ceftazidime in the Treatment of Pneumonia in Pediatric Patients
by: Valen Ruterlin, et al.
Published: (2017-04-01)

Monotherapy of ceftazidime–avibactam and ceftolozane–tazobactam against multidrug-resistant organisms
by: Adnan Alatoom
Published: (2017-09-01)

Ceftolozane/tazobactam and ceftazidime/avibactam for the treatment of complicated intra-abdominal infections
by: Goodlet KJ, et al.
Published: (2016-12-01)

Ceftazidime-avibactam in the treatment of infections from carbapenem-resistant Klebsiella pneumoniae
by: Jie Gu, et al.
Published: (2021-09-01)

Synergy and Mode of Action of Ceftazidime plus Quercetin or Luteolin on Streptococcus pyogenes
by: Supatcharee Siriwong, et al.
Published: (2015-01-01)

Effectiveness of ceftazidime–avibactam versus colistin in treating carbapenem-resistant Enterobacteriaceae bacteremia
by: Hakeam A. Hakeam, et al.
Published: (2021-08-01)

PURIFICATION OF INULINASE FROM KLEBSIELLA PNEUMONIAE AND STUDY THE ANTIBACTERIAL EFFECT OF COMBINATION OF INULINASE AND CEFTAZIDIME
by: Sarah Naji Aziz, et al.
Published: (2019-11-01)

Development of acquired factor V inhibitor after treatment with ceftazidime: a case report and review of the literature
by: Cui QY, et al.
Published: (2015-04-01)

Dynamics of the bacterial gut microbiota in preterm and term infants after intravenous amoxicillin/ceftazidime treatment
by: Romy D. Zwittink, et al.
Published: (2020-05-01)